NCT07412626Not yet recruiting
Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)
HeartLogic Optimization of CHF Medications in Chronic Low EF Population: A Follow-on Study
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
The goal of this trial is to determine if the addition of the Heart Logic diagnostic alerts to standard of care therapies will lessen hospitalizations and improve quality of life in patients with heart failure.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 135 (estimated)
- First submitted
- 9 Feb 2026
- Start date
- 1 Apr 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- Robert Pickett
- Diseases
- Heart failure
- NCT number
- NCT07412626
What you commit to
- Study type: Interventional
- Planned participants: 135
- From 1 Apr 2026 to the primary completion date, Dec 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Documented noncompliance that limits medication use
Other illness
- Patients on Dialysis (renal insufficiency but not on dialysis is NOT an exclusion)
Other
- Refuse to give consent
- Have Life expectancy of less than one-year
- Pregnancy
Who the study is looking for
- Age 18 years or older
- EF \</=35%
- Prior hospitalization within the last two years or prior decompensation to NYHA class III or IV over the last 12 months that was treated without hospitalization
- HeartLogic capable ICD or CRT-D (Patients with HeartLogic capable ICD or CRT-D can be enrolled at time of de novo implantation or generator change out or at the time of the 2 week wound check. Prior Heart logic capable ICF or CRT-D implants can be enrolled if heart failure hospitalization shows decompensation within six months (prior implants must have at least 1 year battery life)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ascension St. Vincent Medical Group Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
| Saint Thomas Heart at Saint Thomas Midtown Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.